Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATPase phospholipid transporting 8B3 is a member of the P-type ATPase (P4-ATPase) family that catalyzes ATP-dependent translocation of aminophospholipids—primarily phosphatidylserine (PS)—across biological membranes, typically from the outer to inner leaflet, thus maintaining membrane phospholipid asymmetry[1][3][4][7]. In humans, it is encoded by the ATP8B3 gene on chromosome 19. ATP8B3 is particularly important for proper sperm function in mammals by regulating PS exposure during capacitation and is implicated in the fertilization process[6]. Variants in ATP8B3 have been associated with differential responses to chemotherapeutic agents such as oxaliplatin in colorectal cancer, making it of interest both as a therapeutic and biomarker target in oncology[4]. ATP8B3 belongs to a broader class of aminophospholipid translocases, many of which have emerging importance in diseases related to membrane biology, including cancer and reproductive disorders[4][6][7].
SNPs affecting ATP8B3 may modulate sensitivity/resistance to oxaliplatin therapy in colorectal cancer, likely through effects on cellular membrane composition or transport
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase phospholipid transporting 8B3 (ATP8B3).